For those navigating the challenging process of coming off the antidepressant sertraline, the most unsettling symptom can often unfold in the silence of the night. Vivid, intensely realistic dreams are a recognised and frequently distressing part of withdrawal, leaving individuals to wake not refreshed, but emotionally shaken and confused.
The Unsettling Nightly Reality
This phenomenon is not merely anecdotal. On forums like Reddit, users share their experiences in search of reassurance. One user, @wwapiti, described the persistence of “weird and vivid dreams” as extremely distressing, noting they were emotionally lingering and upsetting. While other common withdrawal symptoms like “brain zaps”—brief electric shock-like sensations—or dizziness are often mentioned, it is the visceral, cinematic quality of these dreams that can have a lasting impact on a person’s wellbeing. Another user, @whenitrainzz, offered a different perspective, viewing the dreams as a way for her brain to “make sense of what’s going on in [her] subconscious mind”. However, the intensity is universal, causing confusion upon waking as the dreams feel profoundly real.
The Science of Sleep and Serotonin
Psychologist Dr Nikita Amin explains that the root cause lies in one key chemical: serotonin. Sertraline is a selective serotonin reuptake inhibitor (SSRI), meaning it works by increasing the level of serotonin available in the brain. This neurotransmitter plays a crucial, complex role in regulating sleep, particularly the Rapid Eye Movement (REM) stage most closely associated with dreaming.
Herein lies the paradox: while serotonin is involved in sleep regulation, increased serotonin activity from an SSRI can actually suppress REM sleep. As a result, while taking the medication, dreams may become less vivid or harder to recall. The trouble begins when the medication is withdrawn. As serotonin levels decrease, the brain’s suppressed REM sleep can come surging back in a compensatory process known as “REM rebound.” This is the body’s natural response to a period of REM inhibition, leading to longer, more frequent, and more intense REM cycles. It is this rebound that manifests as a flood of vivid, often emotionally charged dreams as the brain scrambles to rebalance its chemistry.
Duration and Prevalence of Symptoms
According to Dr Amin, the timeline for these vivid dreams to subside differs from person to person. Typically, they peak between four and 14 days after stopping the medication and can last for a few weeks as the brain adjusts. For most, symptoms tend to subside within three to six weeks. Research indicates that prolonged use of antidepressants (over two years) may increase the likelihood of experiencing more severe and longer-lasting withdrawal effects.
Understanding how common such withdrawal symptoms are is critical, given the scale of antidepressant use. In 2024 alone, NHS England data reveals sertraline was prescribed more than 24 million times in England. A broader look shows over 91 million antidepressant prescriptions were dispensed that year—the highest annual total on record. Between March 2020 and March 2025, over 428 million antidepressants were issued in England.
However, a 2024 meta-analysis of randomised controlled trials published in The Lancet Psychiatry offers a nuanced view. It found that approximately 15% of patients experience one or more discontinuation symptoms directly caused by stopping the drugs, with about 2-3% suffering severe symptoms. This contrasts with earlier research suggesting over half of patients experience withdrawal, a discrepancy some experts suggest may be partly influenced by the nocebo effect, where negative expectations contribute to symptoms.
A Spectrum of Withdrawal Effects
Vivid dreams sit on a long list of potential withdrawal symptoms, which mental health professionals stress should be managed carefully. Besides dreams, these can include dizziness, nausea, headaches, insomnia, irritability, anxiety, fatigue, flu-like symptoms, confusion, and in rare cases, seizures or increased suicidality. Distinguishing between withdrawal and a relapse of the original depression or anxiety can be challenging, though withdrawal symptoms generally appear and disappear more quickly if the antidepressant is reintroduced.
Because of these risks, bodies like the Royal College of Psychiatrists strongly advise against stopping medication abruptly. The consensus is a gradual, personalised tapering schedule, developed with a doctor. A proportionate taper—where dose reductions are a percentage of the previous dose—is recommended over linear cuts to minimise symptoms. For some individuals, this process may need to extend over months or even years, potentially using liquid preparations to achieve smaller, more manageable dose reductions. Throughout this process, patients are encouraged to track their symptoms daily and maintain close communication with their healthcare provider.